June 5, 2025 - 04:44

A panel scheduled for June 10 will bring together leading experts to delve into the critical intersection of Endpoint Detection and Response (EDR) technology with academic research and privacy concerns. As organizations increasingly rely on EDR systems to enhance their cybersecurity posture, understanding the underlying academic principles and research is essential for effective implementation.
The discussion will cover various aspects of EDR technology, including its mechanisms, advantages, and potential drawbacks. Participants will examine how these systems can detect and respond to threats in real-time, thereby safeguarding sensitive information and maintaining privacy standards. Additionally, the panel will address the ethical implications of using such technologies in academic settings and beyond.
By fostering a dialogue between cybersecurity professionals and academic researchers, the event aims to illuminate the best practices for integrating EDR technology into existing frameworks, ensuring that both security and privacy are upheld in an ever-evolving digital landscape.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...